FT : Rent payment clue in the hunt for Wirecard’s Jan Marsalek

Rent payment clue in the hunt for Wirecard’s Jan Marsalek
Munich police investigated €80,000 transfer to landlord of fugitive executive’s fiancée

Munich police have investigated an €80,000 payment from a bank account in Dubai to the landlord of Jan Marsalek’s fiancée in Munich, which could prove a rare link to the fugitive former Wirecard executive.

The 41-year old Austrian fled in June 2020 just days before Wirecard crashed into insolvency after admitting that €1.9bn of cash and half of its revenues did not exist. Marsalek, who is on Interpol’s most wanted list, is accused of “fraud in the billions” by Munich prosecutors.

The crash of the once high-flying electronic payments company, which at its peak in 2018 was a member of Germany’s blue-chip Dax stock index worth €24bn, is one of Europe’s biggest postwar accounting scandals.

Marsalek left behind his longtime girlfriend in Munich, who has been interrogated by police several times, according to people briefed on the investigation. As Marsalek and his girlfriend were engaged, she can claim spousal privilege and refuse to give testimony.

Marsalek’s fiancée was renting a luxury flat in Munich, paying a monthly rent of about €6,600. Earlier this year, her landlord received a one-off payment of close to €80,000, representing the value of 12 months’ rent.

The money was wired from a bank account in Dubai from a person with an Arabic name, and came with the reference “für Jan” (“on behalf of Jan”). The money was wired to the bank account used to administer the tenant’s deposit, which is different from the one used to settle the monthly rent payments, people briefed on the matter told the Financial Times. The landlord reported the payment to police, according to these people.

A spokeswoman for Munich’s public prosecutors told the FT that investigators received a suspicious activity report from the landlord’s bank in that context, and declined to comment further on the payment, which was first reported by Handelsblatt.

It is unclear if the person in whose name the money was sent really exists, or if it was an alias used by Marsalek. A name very similar to the sender’s is listed as a client of one of Wirecard’s Asian business partners in one of the documents reviewed by KPMG during its special audit into Wirecard.

Lawyers for Marsalek and his fiancée did not immediately respond to requests for comment.

Marsalek is one of the most wanted white collar suspects globally. One day after Wirecard’s auditor EY in June 2020 refused to sign off the group’s 2019 results, Marsalek took a taxi to a small airport in Austria, where he boarded a private jet that he paid in cash, according to an Austrian police document seen by the FT.

He flew to Minsk, where his trace was lost. “We will eventually get him,” Munich’s chief prosecutor Hildegard Bäumler-Hösl told MPs during a parliamentary inquiry into the scandal earlier this year.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • MANU -1.8%, USNA -0.8% (guides Q3 revs below single est, lowers FY21 guidance; increases share repurchase program)

Other news:

  • PTGX -50.7% (receives Clinical Hold from FDA on Rusfertide clinical development program)
  • TPB -4.8% (receives MDO on PMTA process)
  • X -2.1% (announces exploratory site selection process to build new $3 bln mini mill in the US; also guides EBITDA slightly above consensus)
  • SGMS -1.5% (names new CFO)
  • GRFS -1.5% (entered into a share purchase agreement with Tiancheng International Investment Limited)
  • CARR -1% (to acquire BrokerBay)

Analyst comments:

  • CRUS -3% (downgraded to Underperform from Neutral at BofA Securities)
  • CREE -2.8% (downgraded to Underperform from Neutral at BofA Securities)
  • EQNR -1.3% (downgraded to Underweight from Neutral at JP Morgan)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • BPTS +5%

Other news:

  • ABCL +10.3% (FDA expands EUA for bamlanivimab 700 mg and etesevimab 1400 mg to include post-exposure prophylaxis to prevent SARS-CoV-2 infection or symptomatic COVID-19)
  • AGEN +6.3% (Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMO)
  • FANG +5.4% (approves up to $2.0 bln in new repurchase program)
  • VBLT +4.6% (announces independent data safety monitoring committee provides clearance to continue the OVAL phase 3 registration-enabling study of VB-111 in Ovarian Cancer)
  • ZUMZ +3.4% (approves $150 mln stock repurchase authorization)
  • CLNN +2.9% (Presents Phase 2 CNM-Au8 CNS Target Engagement Data at the International Parkinson and Movement Disorder Society Virtual Congress 2021)
  • GRTS +2.7% (announces $55 mln private placement financing)
  • CVGW +1.4% (interim CEO/interim CFO purchased 5000 shares at $36.12 per share (transaction date 9/14))
  • PCG +1.1% (filed an application with the California Public Utilities Commission requesting cost recovery of ~$1.47 bln of recorded expenditures related to wildfire mitigation certain catastrophic events and a number of other activities)
  • GLPG +1.1% (confirms that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for Jyseleca)
  • GLT +1% (will increase prices for all composite fibers products by 12%)

Analyst comments:

  • HSBC +1.7% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
  • ACCD +1.2% (upgraded to Outperform from Neutral at Robert W. Baird)

FT : AQR hedge fund suffers $10bn in outflows

AQR hedge fund suffers $10bn in outflows
Client withdrawals knock assets despite a recovery across other portfolios

Assets in a hedge fund run by AQR have tumbled more than $10bn over the past four years, as a lengthy period of poor returns has persuaded many clients to pull out their cash.

The AQR Managed Futures Strategy fund, a computer-driven mutual fund that tries to profit from market trends, has fallen in size from about $12bn in late 2017 to $1.5bn currently, according to fund documents. While the fund’s bets have often lost money in recent years, most of the drop in assets pertains to client withdrawals.

The outflows come even as Connecticut-based AQR has enjoyed a stronger period of performance more broadly across many of its portfolios, after shedding $86bn in assets from its peak.

AQR, which manages about $140bn in total assets and is headed by former Goldman Sachs managing director Cliff Asness, is well known for its academic approach to investing. It breaks down hedge fund returns into their basic components before building relatively low-cost portfolios to try and exploit those characteristics.

AQR declined to comment.

The AQR Managed Futures Strategy fund is one of the best-known funds in the trend-following sector. Such funds use algorithms to try to identify and then latch on to persistent up or down trends in global futures markets.

However, the fund has often struggled to make money. While it gained 5.4 per cent last March during the stock market’s huge sell-off, it is down 3.9 per cent over the past five years and is roughly flat over the past decade according to fund documentation.

The fund has slipped 2.7 per cent in the first eight months of 2021, even as many of its peers are profiting.

Among those peers sits Man Group’s $1.4bn AHL Diversified fund, which is up 10.3 per cent to mid-month. Aspect Capital’s $3bn Diversified fund has gained 10.5 per cent this year, while GSA’s Trend fund is up 7.2 per cent, according to numbers sent to investors and people familiar with the performance.

Managed futures funds are up 7.8 per cent on average this year to the end of August, according to data group HFR. Many such funds have profited as the easing of coronavirus lockdowns and continued central bank stimulus have pushed riskier financial markets higher.

The S&P 500 index has risen 19 per cent in a near-straight line this year, while Brent crude is up 44 per cent. 

AQR’s fund tries to profit from both short and long-term market trends, and to spot when trends have run too far and are about to reverse. The fund has been running bets on the rising price of oil futures, but it also has more than a quarter of its assets in currencies, according to fund documentation, where there have been fewer trends to exploit.

AQR has this year benefited from a rebound in lowly-priced, so-called value stocks. Its Equity Market Neutral Global Value fund gained 12.3 per cent between the start of January and the end of August, while its Absolute Return strategy is up 13.3 per cent.

>>> Europe : Brokers Upgrades & Downgrades - 17th of September 2021 V2(+)

>>> Up
* Evraz Raised to Overweight at Morgan Stanley; PT 680 pence
* Eni Raised to Overweight at JPMorgan; PT 15 euros
* Glencore Raised to Overweight at Morgan Stanley; PT 360 pence
* HSBC Raised to Overweight at Barclays; PT 530 pence
* HSBC Raised to Outperform at RBC; PT 460 pence
* InterContinental Hotels Raised to Buy at Berenberg
* Kruk Raised to Neutral at Citi
* Maersk Raised to Hold at Danske Bank Markets; PT 21,000 kroner (+)
* Metsa Board Raised to Buy at Carnegie; PT 10.80 euros
* Piaggio Raised to Buy at Banca Akros (ESN); PT 3.80 euros (+)
* Prodways Raised to Outperform at Oddo BHF (+)
* Repsol Raised to Overweight at JPMorgan; PT 14 euros
* Ryanair Raised to Buy at Peel Hunt; PT 21 euros (+)
* Sava Re Cut to Hold at Wood & Company; PT 30.70 euros (+)
* Standard Chartered Raised to Equal-Weight at Barclays
* Storebrand Raised to Hold at Kepler Cheuvreux; PT 80 kroner (+)
* Wickes Raised to Buy at Deutsche Bank; PT 313 pence

>>> Down
* Anglo American Cut to Equal-Weight at Morgan Stanley
* Autoliv Cut to Underperform at Exane; PT $87
* Equinor Cut to Underweight at JPMorgan; PT 190 kroner
* Ferrari Cut to Neutral at Exane; PT $256
* Galp Cut to Underweight at JPMorgan; PT 10 euros
* Lonza Cut to Equal-Weight at Morgan Stanley; PT 810 Swiss francs
* ManpowerGroup Cut to Underweight at Barclays; PT $120
* OMV Cut to Neutral at JPMorgan; PT 58 euros
* TotalEnergies Cut to Neutral at JPMorgan; PT 48 euros
* Trustpilot Cut to Neutral at JPMorgan; PT 410 pence
* Trustpilot Cut to Hold at Danske Bank Markets; PT 396 pence

>>> Initiation
* Hutchmed China Rated New Buy at CMB International
* Multitude SE Re-Initiated Buy at Hauck & Aufhaeuser (+)
* Recordati Rated New Equal-Weight at Barclays; PT 50 euros
* Vitesco Technologies Group Rated New Buy at Deutsche Bank

>>> Call
* Barry Callebaut Share-Price Weakness Is Buying Opportunity: Citi (+)
* Glencore ‘Has More to Play For,’ Anglo Cut: Morgan Stanley
* IHG Raised at Berenberg on Supportive Trends, Overdone Concerns
* HSBC Up to Outperform at RBC With Shares at Good Entry Point
* HSBC Upgraded at Barclays and RBC on Attractive Valuation (1)
* Lonza Cut at Morgan Stanley, AstraZeneca Among Top Pharma Picks
* Ryanair Upgraded to Buy at Peel Hunt on Strong Bookings (+)